Skip to main content
. 2018 Nov 6;30(11):1349–1354. doi: 10.1589/jpts.30.1349

Table 1. Characteristics of participants.

Overall (n=29) GOLD stage

1 (n=3) 2 (n=11) 3 (n=8) 4 (n=7)
Age (years) 74.0 ± 8.7 59.7 ± 4.2 78.0 ± 6.0 75.5 ± 4.2 72.3 ± 11.3
Height (cm) 163.3 ± 8.5 172.3 ± 6.8 165.4 ± 7.4 162.8 ± 6.1 157.0 ± 9.9
Weight (kg) 58.7 ± 11.2 65.0 ± 4.4 64.6 ± 10.6 57.8 ± 9.2 47.9 ± 8.8
FVC (l) 2.69 ± 1.2 4.80 ± 0.6 3.22 ± 0.5 2.31 ± 0.6 1.40 ± 0.5
FEV1 (l) 1.38 ± 0.8 3.29 ± 0.0 1.64 ± 0.3 0.99 ± 0.2 0.61 ± 0.2
FEV1% (%) 50.6 ± 14.4 69.4 ± 8.8 51.6 ± 10.7 46.5 ± 14.1 45.8 ± 17.1
%FEV1 (%) 52.6 ± 24.0 101.3 ± 4.0 65.7 ± 11.8 41.6 ± 10.0 30.1 ± 56.0
VC (l) 3.13 ± 1.0 5.19 ± 0.2 3.44 ± 0.6 2.66 ± 0.5 2.05 ± 0.6
PImax (cmH2O) 56.1 ± 23.3 75.0 ± 41.0 62.7 ± 20.4 51.0 ± 13.5 43.6 ± 24.3
PEmax (cmH2O) 72.8 ± 31.5 103.7 ± 56.6 81.9 ± 23.2 63.8 ± 31.5 55.4 ± 20.1

Data presented as mean ± SD. GOLD: Global Initiative for Chronic Obstructive Lung Disease; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; FEV1%: FEV1/forced vital capacity (FVC) ratio; %FEV1: FEV1/FEV1predicted; VC, vital capacity; PImax: maximal inspiratory pressure; PEmax: maximal expiratory pressure.